参考文献/References:
[1] di Biase L,Natale A ,Romero J. Thrombogenic and arrhythmogenic roles of the left atrial appendage in atrial fibrillation[J]. Circulation,2018,138(18):2036-2050.
[2] 孙林芳,朱凌燕.老年心房颤动患者抗凝服药依从性及其影响因素分析[J]. 心血管病学进展,2020,41(9):978-983.
[3] Vuddanda VLK,Turagam MK,Umale NA,et al. Incidence and causes of in-hospital outcomes and 30-day readmissions after percutaneous left atrial appendage closure:A US nationwide retrospective cohort study using claims data[J]. Heart Rhythm,2020,17(3):374-382.
[4] Basu Ray I,Khanra D,Shah S,et al. Meta-analysis comparing WatchmanTM and Amplatzer devices for stroke prevention in atrial fibrillation [J]. Front Cardiovasc Med,2020,7:89.
[5] January CT,Wann LS,Calkins H,et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons[J]. Circulation,2019,140(2):e125-e151.
[6] Hindricks G,Potpara T,Dagres N,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)[J]. Eur Heart J,2021,42(5):373-498.
[7] Boersma LV,Ince H,Kische S,et al. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation:1-Year follow-up outcome data of the EWOLUTION trial[J]. Heart Rhythm,2017,14(9):1302-1308.
[8] Fauchier L,Cinaud A,Brigadeau F,et al. Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation[J]. J Am Coll Cardiol,2018,71(14):1528-1536.
[9] 周达新，葛均波，张晓春，等. 中国经导管左心耳封堵术临床路径专家共识[J]. 中国介入心脏病学杂志,2019,27(12):661-672.
[10] Berti S,Santoro G,Brscic E,et al. Left atrial appendage closure using AMPLATZER devices:a large,multicenter,Italian registry [J]. Int J Cardiol,2017,248:103-107.
[11] Adler Y,Charron P,Imazio M,et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases:The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology(ESC) Endorsed by:The European Association for Cardio-Thoracic Surgery(EACTS)[J]. Eur Heart J,2015,36(42):2921-2964.
[12] 江立生，何奔，马长生，等. 中国左心耳封堵预防心房颤动卒中专家共识(2019)[J]. 中华心血管病杂志,2019,47(12):937-955.
[13] Segers VFM,Heidbuchel H. Evidence and indications for percutaneous closure of the left atrial appendage[J]. Rev Esp Cardiol(Engl Ed),2018,71(9):700-702.
[14] Reddy VY,Gibson DN,Kar S,et al. Post-approval U.S. experience with left atrial appendage closure for stroke prevention in atrial fibrillation[J]. J Am Coll Cardiol,2017,69(3):253-261.
[15] Zwirner J,Bayer R,H?drich C,et al. Pulmonary artery perforation and coronary air embolism—two fatal outcomes in percutaneous left atrial appendage occlusion[J]. Int J Legal Med,2017,131(1):191-197.
[16] Mobius-Winkler S,Majunke N,Sandri M,et al. Percutaneous left atrial appendage closure:technical aspects and prevention of periprocedural complications with the watchman device[J]. World J Cardiol,2015,7(2):65-75.
[17] Lempereur M,Aminian A,Freixa X,et al.Device-associated thrombus formation after left atrial appendage occlusion:a systematic review of events reported with the Watchman,the Amplatzer Cardiac Plug and the Amulet [J]. Catheter Cardiovasc Interv,2017,90(5):E111-E121.
[18] Black-Maier E,Piccini JP,Granger CB. Left atrial appendage closure:a therapy uniquely suited for specific populations of patients with atrial fibrillation [J]. J Cardiovasc Electrophysiol,2019,30(12):2968-2976.
[19] Boersma LV,Ince H,Kische S,et al. Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology: final 2-year outcome data of the EWOLUTION trial focusing on history of stroke and hemorrhage[J]. Circ Arrhythm Electrophysiol,2019,12(4):e006841.
[20] Torres-Saura F,Pérez-de Prado A,Romero-Vazquiánez M,et al. Catheter-based closure of residual leaks after percutaneous occlusion of the left atrial appendage with WATCHMAN device:two cases[J]. Rev Esp Cardiol(Engl Ed),2020,73(3):262-263.
[21] Wilkins B,Fukutomi M,de Backer O,et al. Left atrial appendage closure: prevention and management of periprocedural and postprocedural complications [J]. Card Electrophysiol Clin,2020,12(1):67-75.
[22] Turagam MK,Velagapudi P,Kar S,et al. Cardiovascular therapies targeting left atrial appendage[J]. J Am Coll Cardiol,2018,72(4):448-463.
[23] Nguyen A,Gallet R,Riant E,et al. Peridevice leak after left atrial appendage closure: incidence, risk factors, and clinical impact[J]. Can J Cardiol,2019,35(4):405-412.
[24] Della Rocca DG,Horton RP,Tarantino N,et al. Use of a novel septal occluder device for left atrial appendage closure in patients with postsurgical and postlariat leaks or anatomies unsuitable for conventional percutaneous occlusion[J]. Circ Cardiovasc Interv,2020,13(10):e009227.
[25] Mohanty S,Gianni C,Trivedi C,et al. Risk of thromboembolic events after percutaneous left atrial appendage ligation in patients with atrial fibrillation:long-term results of a multicenter study[J]. Heart Rhythm,2020,17(2):175-181.
[26] Della Rocca DG,Horton RP,di Biase L,et al. First experience of transcatheter leak occlusion with detachable coils following left atrial appendage closure[J]. JACC Cardiovasc Interv,2020,13(3):306-319.
[27] Mohanty S,Trivedi C,Beheiry S,et al. Venous access-site closure with vascular closure device vs. manual compression in patients undergoing catheter ablation or left atrial appendage occlusion under uninterrupted anticoagulation:a multicentre experience on efficacy and complications[J]. Europace,2019,21(7):1048-1054.
[28] 李玉豪,雷长城.经皮左心耳封堵术在预防心房颤动患者脑卒中的应用前景[J].心血管病学进展,2019,40(8):1083-1087.
[29] Kavinsky CJ,Kusumoto FM,Bavry AA,et al. SCAI/ACC/HRS institutional and operator requirements for left atrial appendage occlusion[J]. J Am Coll Cardiol,2016,67(19):2295-2305.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(5):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(5):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
[11]安硕研,郑金刚.左心耳封堵术预防心源性卒中的进展[J].心血管病学进展,2019,(6):869.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.008]
AN Shuoyan,ZHENG Jingang.Left Atrial Appendage Closure for Prevention of Cardiogenic Stroke[J].Advances in Cardiovascular Diseases,2019,(5):869.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.008]
[12]柏懿璇 崔凯军.左心耳封堵术后装置相关血栓[J].心血管病学进展,2022,(5):407.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.006]
BAI Yixuan,CUI Kaijun.Device-Related Thrombus After Left Atrial Appendage Occlusion[J].Advances in Cardiovascular Diseases,2022,(5):407.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.006]
[13]王璐 李耀东.TAVR合并心房颤动抗凝策略的研究进展[J].心血管病学进展,2022,(8):695.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.007]
WANG Lu,LI Yaodong.Anticoagulation Strategy in Patients After TAVR Complicated with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(5):695.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.007]
[14]魏志梁 孙雨可 尹月娇 孙守刚.心房颤动合并慢性肾脏病患者的左心耳封堵治疗研究进展[J].心血管病学进展,2022,(9):783.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.005]
WEI Zhiliang,SUN Yuke,YIN Yuejiao,et al.Left Atrial Appendage Closure in Patients with Atrial Fibrillation Complicated with Chronic Kidney Disease[J].Advances in Cardiovascular Diseases,2022,(5):783.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.005]
[15]加依娜·加尔肯 汤宝鹏 周贤惠 李耀东 芦颜美.非瓣膜性心房颤动患者“一站式”手术策略的有效性和安全性:单中心经验[J].心血管病学进展,2022,(12):1141.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.019]
Jiayina Jiaerken,TANG Baopeng,ZHOU Xianhui,et al.Effectiveness and Safety of "One-Step" Procedure in Patients with Non-Valvular Atrial Fibrillation:A Single Center Experience?/html>[J].Advances in Cardiovascular Diseases,2022,(5):1141.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.019]